Get the latest healthcare market updates, stock performance, and key pharma news, including Trump’s drug price push and major industry deals.

Nordisk and Eli Lilly are set to reshape the oral GLP-1 market as patient demand grows and new therapies emerge. Learn more ...

Novo Nordisk layoffs and Orsted’s offshore wind troubles expose the risks of Denmark’s reliance on a handful of corporate giants ...

The S&P 500 and Nasdaq Composite set new closing highs Wednesday, with stocks aided by cooler-than-expected inflation data ...

One of them is already a leader in the market for weight management drugs, and the other could join this field.

The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

The biopharma job market remains challenging, based on BioSpace data. In August, job postings live on the website dropped 32% ...

Novo Nordisk - makers of Ozempic - is set to lay off 9,000 staff members, or 11.5 % of its workforce. Five thousand of the ...

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 ...

At their heights, Denmark’s corporate champions seemed untouchable. Novo Nordisk A/S, long known mostly as an insulin maker, was Europe’s most valuable company last year, after riding a surge of ...

Stocks have been hitting records in large part because Wall Street is expecting the economy to pull off a delicate balancing ...